Adenomyosis: A Challenge in Clinical Gynecology

Journal of Midwifery and Women's Health

Volumn 57, Issue 3, 2012, Pages 212-220

  Cockerham, Anne Z ^a  

^a NONE   (United States)

Author keywords

Adenomyosis; Dysmenorrhea; Levonorgestrel releasing intrauterine system; Menorrhagia; Myometrium; Tranexamic acid

Indexed keywords

DESOGESTREL; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; GONADORELIN AGONIST; IBUPROFEN; LEUPRORELIN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PLACEBO; PROSTAGLANDIN SYNTHASE; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID; VALPROIC ACID;

ADENOMYOSIS; BACKACHE; BIPOLAR DISORDER; BONE DENSITY; CLINICAL FEATURE; COLOR VISION DEFECT; DIAGNOSTIC IMAGING; DIARRHEA; DRUG WITHDRAWAL; DYSMENORRHEA; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM ABLATION; EPILEPSY; FATIGUE; FEMALE; GYNECOLOGY; HEADACHE; HEALTH CARE PERSONNEL; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HOT FLUSH; HUMAN; HYSTERECTOMY; MENORRHAGIA; MOOD CHANGE; MUSCULOSKELETAL PAIN; MYOMETRIUM; NAUSEA; NOSE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS PAIN SYNDROME; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIDE EFFECT; SINUS NODE DISEASE; SUBFERTILITY; TRANSVAGINAL ECHOGRAPHY; VAGINA ATROPHY; VOMITING;

EID: 84862076293     PISSN: 15269523     EISSN: 15422011     Source Type: Journal    
DOI: 10.1111/j.1542-2011.2011.00117.x     Document Type: Review

References (59)

1. Champaneria R, Abedin P, Daniels J, Balogun M, Khan KS. Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy. Acta Obstet Gynecol. 2010;89:1374-1384.
2. Liu X, Yuan L, Guo SW. Valproic acid as a therapy for adenomyosis: a comparative case series. Reprod Sci. 2010;17(10):904-912.
3. Bergeron C, Amant F, Ferenczy A. Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynecol. 2006;20(4):511-521.
4. Liu X, Nie J, Guo, SW. Elevated immunoreactivity to tissue factor and its association with dysmenorrhea severity and the amount of menses in adenomyosis. Hum Reprod. 2011;26(2):337-345.
5. Hudelist G, Keckstein J, Wright JT. The migrating adenomyoma: past views on the etiology of adenomyosis and endometriosis. Fertil Steril. 2009;92(5):1536-1543.
6. Taran FA, Weaver, AL, Coddington CC, Stewart EA. Understanding adenomyosis: a case control study. Fertil Steril. 2010;94(4):1223-1228.
7. Farquhar C, Brosens I. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynecol. 2006;20(4):603-616.
8. Gordts S. Uterine adenomyosis: a need for uniform terminology and consensus classification. Reprod Biomed Online. 2008;17(2):244-248.
9. Woodfield CA, Siegelman ES, Coleman BG, Torigian DA. CT features of adenomyosis. Eur J Radiol. 2009;72: 464-469.
10. Meredith SM, Sanchez-Ramos L, Kaunitz AM. Diagnostic accuracy of transvaginal sonography for the diagnosis of adenomyosis: systematic review and metaanalysis. Am J Obstet Gynecol. 2009;201:107.e1-e6.
11. Lone FW, Balogun M, Khan KS. Adenomyosis: not such an elusive diagnosis any longer. J Obstet Gynecol. 2006;26(3):225-228.
12. Maseelall P, Weiss G. Adenomyosis: more common than you'd think. Contemp Ob Gyn. 2008;53(2):38-47.
13. Rodriguez MI, Warden M, Darney PD. Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications. Am J Obstet Gynecol. 2010;202(5):420-428.
14. Yeniel O, Cirpan T, Ulukus M, et al. Adenomyosis: prevalence, risk factors, symptoms and clinical findings. Clin Exp Obstet Gynecol. 2007;34(3):163-167.
15. Vercellini P, Viganò P, Somigliana E, Daguati R, Abbiati A, Fedele L. Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet Gynecol. 2006;20(4):465-477.
16. Leyendecker G, Wildt L, Mall, G. The pathophysiology of endometriosis and adenomyosis: tissue injury and repair. Arch Gynecol Obstet. 2009;280:529-538.
17. Levgur M. Diagnosis of adenomyosis: a review. J Reprod Med. 2007;52:177-193.
18. Peric H, Fraser IS. The symptomatology of adenomyosis. Best Pract Res Clin Obstet Gynecol. 2006;20(4):547-555.
19. Quinn M. Uterine innervation in adenomyosis. J Obsetr Gynecol. 2007;27(3):287-291.
20. Templeman C, Marshall SF, Ursin G, et al. Adenomyosis and endometriosis in the California Teachers Study: reproductive and lifestyle correlates. Fertil Steril. 2008;90(2):415-424.
21. Taran FA, Weaver, AL, Coddington CC, Stewart EA. Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study. Hum Reprod. 2010;25(5):1177-1182.
22. Itam SP, Ayensu-Coker L, Sanchez J, Zurawin RK, Dietrich JE. Adenomyosis in the adolescent population: a case report and review of the literature. J Pediatr Adolesc Gynecol. 2009;22:e146-e147.
23. Tocci A. Adenomyosis and 'endometrial subendometrial myometrium unit disruption disease' are two different entities. Reprod Biomed Online. 2008;17(2):285-295.
24. Mehasseb MK, Bell SC, Pringle JH, Habiba MA. Uterine adenomyosis is associated with ultrastructural features of altered contractility in the inner myometrium. Fertil Steril. 2010;93(7):2130-2136.
25. Basak S, Saha A. Adenomyosis: still largely under-diagnosed. J Obstet Gynecol. 2009;29(6):533-535.
26. Kunz G. Adenomyosis as a disorder of the early and late human reproductive period. Reprod Biomed Online. 2007;15(6):681-685.
27. Zhou M, Chen JY, Tang LD, Chen WZ, Wang ZB. Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center. Fertil Steril. 2011;95(3):900-905.
28. Goh SL, Chua NWL, Chern B SM. Adenomyosis with extremely elevated CA 125 levels. Int J Gynecol Obstet. 2009;10(2).
29. Vercellini P, Cortesi I, De Giorgi O, et al. Transvaginal ultrasonography versus uterine needle biopsy in the diagnosis of diffuse adenomyosis. Hum Reprod. 1998;13:2884-2887.
30. Borgatta L, Roncari D. Management strategies for heavy menstrual bleeding. J Clin Outcomes Manag. 2010;17(12):565-575.
31. Kruszka P, Kruska S. Evaluation of acute pelvic pain in women. Am Fam Physician. 2010;82(2):141-147.
32. Stoelting-Gettelfinger W. A case study and comprehensive differential diagnosis and care plan for the three Ds of women's health: Primary dysmenorrhea, secondary dysmenorrhea, and dyspareunia. J Am Acad Nurse Pract. 2010;22:513-522.
33. Ely JW, Kennedy CM, Clark EC, Bowdler NC. Abnormal uterine bleeding: A management algorithm. J Am Board Fam Med. 2006;19:590-602.
34. Levgur M. Therapeutic options for adenomyosis: a review. Arch Gynecol Obstet. 2007;276:1-15.
35. Maia H, Casoy J. Non-contraceptive health benefits of oral contraceptives. Eur J Contracept Reprod Health Care. 2008;13(1):17-24.
36. Schindler AE. Hormonal contraceptives and endometriosis/adenomyosis. Gynecol Endocrinol. 2010;26(12):851-854.
37. Schweppe KW. Long-term use of progestogens-effects on endometriosis, adenomyosis and myomas. Gynecol Endocrinol. 2007;23(S1):17-21.
38. Schweppe KW. The place of dydrogesterone in the treatment of endometriosis and adenomyosis. Maturitas. 2009;65S:S23-S27.
39. Fedele L, Bianchi S, Frontino G. Hormonal treatments for adenomyosis. Best Pract Res Clin Obstet Gynecol. 2008;22(2):333-339.
40. Lethaby A, Augood C, Duckitt K, Farquhar C. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev. 2007;(4):CD000400.
41. Tranexamic acid (Lysteda) for treatment of menorrhagia. Med Lett Drugs Ther. 2010;52(1342):54-55.
42. US Food and Drug Administration. FDA approved Lysteda to treat heavy menstrual bleeding. 2009. Accessed March 12, 2011.
43. Kaunitz AM. A new treatment for menorrhagia enters the US market. OBG Manag. 2010;22(6):34-35.
44. Lukes AS, Moore KA, Muse KN, et al. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol. 2010;116(4):865-875.
45. Philipp CS. Antifibrinolytics in women with menorrhagia. Thromb Res. 2011;127:S113-S115.
46. Marret H, Fauconnier A, Chabbert-Buffet N, et al. Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause. Eur J Obstet Gynecol Reprod Biol. 2010;152(2):133-137.
47. Guo SW. Epigenetics of endometriosis. Mol Hum Reprod. 2009;15(10):587-607.
48. Liu X, Guo SW. A pilot study on the off-label use of valproic acid to treat adenomyosis. Fertil Steril. 2008;89(1):246-250.
49. Jensen JT. Don't forget the other benefits of the levonorgestrel IUS. Contemp Ob Gyn. 2007;52(1):46-57.
50. Cho S, Nam A, Kim H, et al. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis. Am J Obstet Gynecol. 2008;198:373.e1-373.e7.
51. Bayer HealthCare Pharmaceuticals [Mirena prescribing information]. 2009. Accessed July 22, 2011.
52. Fedele L, Bianchi S, Raffaelli R, et al. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil Steril. 1997;68:426-429.
53. Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-Lax E, Muysers C, Jensen JT. Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol. 2010;116(3):625-632.
54. Bragheto AM, Caserta N, Bahamondes L, Petta CA. Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging. Contraception. 2007;76:195-199.
55. Fraser IS. Non-contraceptive health benefits of intrauterine hormonal systems. Contraception. 2010;82:396-403.
56. Sheng J, Zhang WY, Zhang JP, Lu D. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of the levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception. 2009;79:189-193.
57. Ozdegirmenci O, Kayikcioglu F, Akgul MA, et al. Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis. Fertil Steril. 2011;95(2):497-502.
58. Rabinovici J. New interventional techniques for adenomyosis. Best Pract Res Clin Obstet Gynecol. 2006;20(4):617-638.
59. Bratby MJ, Walker WJ. Uterine artery embolisation for symptomatic adenomyosis-mid-term results. Eur J Radiol. 2009;70:128-132.